Japan boasts a highly advanced and well-established healthcare infrastructure. The country is known for its modern hospitals, cutting-edge medical technologies, and a high standard of patient care. This advanced infrastructure includes the use of state-of-the-art IV equipment Japan has one of the world's most rapidly aging populations. With an increasing number of elderly individuals, there is a higher prevalence of chronic diseases that often require intravenous therapies. IV equipment plays a crucial role in delivering medications and nutrients to manage these conditions. There is a cultural emphasis on patient-centric care in Japan. This involves tailoring healthcare services to meet individual patient needs and preferences. IV equipment is selected and used with a focus on providing the best possible care experience for each patient. According to a 2022 report from the Japanese Ministry of Health, Labour and Welfare, there were an estimated 1.4 million people in Japan who used intravenous (IV) equipment in the past year. This number has been steadily increasing in recent years, as more and more people are diagnosed with chronic diseases that require IV therapy. The most common conditions requiring IV therapy in Japan are cancer, heart disease, and diabetes. IV Equipments are generally costly in Japan. The cost of IV equipment can vary depending on the specific type of equipment, the brand, and the retailer. First, Japan has a high standard of healthcare, and IV equipment is considered to be a critical medical device. This means that the government imposes strict regulations on the quality and safety of IV equipment, which can drive up the cost. Japan has a strong pharmaceutical industry, and many of the largest IV equipment manufacturers are Japanese companies. This can create a situation where there is less competition in the IV equipment market, which can also drive up prices. An IV pump can cost approximately US$ 85, while a common IV catheter can cost more than US$3.
According to the research report “Japan Intravenous (IV) Equipments Overview, 2028," published by Bonafide Research, the Japan IV Equipments market is anticipated to add more than USD 200 Million from 2023 to 2028. Japan is known for its commitment to technological innovation. In the IV equipment market, this translates to the development and adoption of advanced technologies, such as smart pumps, infusion monitoring systems, and devices with enhanced safety features. Patient safety is a top priority in the Japanese healthcare system. IV equipment in Japan is designed and used with a strong emphasis on safety standards, including features to prevent medication errors, infection control measures, and continuous monitoring capabilities. There has been a gradual shift towards the use of disposable IV systems in Japan. Disposable IV sets and components are preferred for their convenience, reduced risk of contamination, and ease of disposal. Smart infusion pumps with features such as dose error reduction systems (DERS), wireless connectivity, and integration with electronic medical records (EMRs) are becoming more prevalent in Japan. These pumps enhance accuracy, reduce medication errors, and improve workflow efficiency. The COVID-19 pandemic has accelerated the adoption of telemedicine in Japan. This trend includes the use of remote monitoring solutions integrated with IV equipment, allowing healthcare providers to track patients' conditions and adjust treatments remotely. For patients requiring insulin therapy or glucose control, there is a trend toward the integration of IV equipment with continuous blood glucose monitoring systems. This integration allows for more precise control and adjustments in insulin administration.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
In terms of product market is segmented into IV catheters, infusion pumps, administration sets, securement devices, needless connectors, stopcocks and check valves, drip chambers and others. In the Japan IV equipment market, drip chamber products are expanding at a rapid rate. When administering intravenous medication to a patient, drip chambers are essential for preventing air bubbles from getting into their bloodstream. Demand for sophisticated drip chambers that ensure the administration of air-free fluids and effectively regulate air is driven by the emphasis on patient safety and lowers the danger of air embolisms. Drip chambers with features that put the comfort of the patient first during IV therapy are being produced by manufacturers. The popularity of drip chambers among healthcare professionals can be attributed to their ability to improve patient experiences by reducing fluid turbulence, eliminating noise, and optimising drip rates. Drip chambers are used more frequently as a result of ongoing technological advancements. Innovative designs that maximise drip chamber performance and provide more seamless intravenous fluid administration include enhanced air venting systems, extended filtering capabilities, and improved fluid flow dynamics. In Japan, drip chambers are made to meet strict quality standards and legal requirements, guaranteeing their effectiveness and safety. Adherence to these guidelines enhances healthcare professionals' trust in the dependability and efficiency of drip chambers, leading to a rise in their use.
Based on end user segment market is divided into hospitals, clinics, home care settings and others. Clinics are one of the key end users of IV equipment’s in Japan. Numerous medical services, such as outpatient care, specialty treatments, surgery, and diagnostic services are offered by clinics in Japan. In clinical settings, IV equipment is necessary for blood transfusions, medication administration, and hydration. Clinics usually offer specialised care for particular illnesses or therapies. These particular demands are satisfied by IV technology, which enables clinics to offer a wide selection of intravenous medications tailored to the requirements of their patients. IV technology is widely used in oncology, gastrointestinal, and pain management clinics to administer targeted medications. For the accurate and efficient administration of medications and fluids, these institutions rely on contemporary infusion pumps, catheters, and accessories. Efficiency and economical care delivery are frequently given top priority in clinics. Clinics can streamline operations and control costs by effectively managing patient treatments, cutting down on treatment durations, and optimising resource use with IV equipment. IV equipment plays a major role in specialised clinics that treat chronic ailments like rheumatology, haematology, or infectious diseases. These clinics frequently offer long-term therapies that call for the utilisation of cutting-edge IV equipment in order to deliver efficient and ongoing care. IV therapy is used at clinics that specialise in wellness and preventive care to support the immune system, replenish vitamins, or hydrate patients. IV equipment makes it easier to provide these wellness treatments to people who want to take preventative care of their health.
Considered in this report:
• Geography: Japan
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
Aspects covered in this report:
• Japan IV Equipments market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
By Product:
• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others
By End User:
• Hospital
• Clinics
• Home Care Settings
• Others
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
By Indication:
• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.
Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the IV Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
Table of Contents
Table of Contents
1. Executive Summary
2. Market Structure
2.1. Market Considerate
2.2. Assumptions
2.3. Limitations
2.4. Abbreviations
2.5. Sources
2.6. Definitions
2.7. Geography
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Japan Macro Economic Indicators
5. Market Dynamics
5.1. Key Findings
5.2. Key Developments - 2021
5.3. Market Drivers & Opportunities
5.4. Market Restraints & Challenges
5.5. Market Trends
5.6. Covid-19 Effect
5.7. Supply chain Analysis
5.8. Policy & Regulatory Framework
5.9. Industry Experts Views
6. Japan Intravenous (IV) Equipments Market Overview
6.1. Market Size By Value
6.2. Market Size and Forecast By Product
6.3. Market Size and Forecast By End-Use
6.4. Market Size and Forecast By Indication
7. Japan Intravenous (IV) Equipments Market Segmentations
7.1. Japan Intravenous (IV) Equipments Market, By Product
7.1.1. Japan Intravenous (IV) Equipments Market Size, By IV Catheters, 2017-2028
7.1.2. Japan Intravenous (IV) Equipments Market Size, By Infusion Pumps, 2017-2028
7.1.3. Japan Intravenous (IV) Equipments Market Size, By Administration Sets, 2017-2028
7.1.4. Japan Intravenous (IV) Equipments Market Size, By Securement devices, 2017-2028
7.1.5. Japan Intravenous (IV) Equipments Market Size, By Needless Connectors, 2017-2028
7.1.6. Japan Intravenous (IV) Equipments Market Size, By Stopcocks and Check Valves, 2017-2028
7.1.7. Japan Intravenous (IV) Equipments Market Size, By Drip Chambers, 2017-2028
7.1.8. Japan Intravenous (IV) Equipments Market Size, By Others, 2017-2028
7.2. Japan Intravenous (IV) Equipments Market, By End-Use
7.2.1. Japan Intravenous (IV) Equipments Market Size, By Hospitals, 2017-2028
7.2.2. Japan Intravenous (IV) Equipments Market Size, By Clinics, 2017-2028
7.2.3. Japan Intravenous (IV) Equipments Market Size, By Home Care Settings, 2017-2028
7.2.4. Japan Intravenous (IV) Equipments Market Size, By Others, 2017-2028
7.3. Japan Intravenous (IV) Equipments Market, By Indication
7.3.1. Japan Intravenous (IV) Equipments Market Size, By Cardiovascular Disorders & Hypertension, 2017-2028
7.3.2. Japan Intravenous (IV) Equipments Market Size, By Pregnancy, 2017-2028
7.3.3. Japan Intravenous (IV) Equipments Market Size, By Diabetes, 2017-2028
7.3.4. Japan Intravenous (IV) Equipments Market Size, By Respiratory Diseases, 2017-2028
7.3.5. Japan Intravenous (IV) Equipments Market Size, By Cancer, 2017-2028
7.3.6. Japan Intravenous (IV) Equipments Market Size, By Movement Disorders, 2017-2028
7.3.7. Japan Intravenous (IV) Equipments Market Size, By Cancer, 2017-2028
7.3.8. Japan Intravenous (IV) Equipments Market Size, By Movement Disorders, 2017-2028
8. Japan Intravenous (IV) Equipments Market Opportunity Assessment
8.1. By Product, 2023 to 2028
8.2. By End-Use, 2023 to 2028
8.3. By Indication, 2023 to 2028
9. Competitive Landscape
9.1. Porter's Five Forces
9.2. Company Profile
9.2.1. Company 1
9.2.1.1. Company Snapshot
9.2.1.2. Company Overview
9.2.1.3. Financial Highlights
9.2.1.4. Geographic Insights
9.2.1.5. Business Segment & Performance
9.2.1.6. Product Portfolio
9.2.1.7. Key Executives
9.2.1.8. Strategic Moves & Developments
9.2.2. Company 2
9.2.3. Company 3
9.2.4. Company 4
9.2.5. Company 5
9.2.6. Company 6
9.2.7. Company 7
9.2.8. Company 8
10. Strategic Recommendations
11. Disclaimer
List of Table
Table 1 : Influencing Factors for Global Intravenous (IV) Equipments Market, 2022
Table 2: Japan Intravenous (IV) Equipments Market Size and Forecast By Product (2017, 2022 & 2028F)
Table 3: Japan Intravenous (IV) Equipments Market Size and Forecast By End-Use (2017, 2022 & 2028F)
Table 4: Japan Intravenous (IV) Equipments Market Size and Forecast By Indication (2017, 2022 & 2028F)
Table 5: Japan Intravenous (IV) Equipments Market Size of IV Catheters (2017 to 2028) in USD Million
Table 6: Japan Intravenous (IV) Equipments Market Size of Infusion Pumps (2017 to 2028) in USD Million
Table 7: Japan Intravenous (IV) Equipments Market Size of Administration Sets (2017 to 2028) in USD Million
Table 8: Japan Intravenous (IV) Equipments Market Size of Securement devices (2017 to 2028) in USD Million
Table 9: Japan Intravenous (IV) Equipments Market Size of Needless Connectors (2017 to 2028) in USD Million
Table 10: Japan Intravenous (IV) Equipments Market Size of Stopcocks and Check Valves (2017 to 2028) in USD Million
Table 11: Japan Intravenous (IV) Equipments Market Size of Drip Chambers (2017 to 2028) in USD Million
Table 12: Japan Intravenous (IV) Equipments Market Size of Others (2017 to 2028) in USD Million
Table 13: Japan Intravenous (IV) Equipments Market Size of Hospitals (2017 to 2028) in USD Million
Table 14: Japan Intravenous (IV) Equipments Market Size of Clinics (2017 to 2028) in USD Million
Table 15: Japan Intravenous (IV) Equipments Market Size of Home Care Settings (2017 to 2028) in USD Million
Table 16: Japan Intravenous (IV) Equipments Market Size of Others (2017 to 2028) in USD Million
Table 17: Japan Intravenous (IV) Equipments Market Size of Cardiovascular Disorders & Hypertension (2017 to 2028) in USD Million
Table 18: Japan Intravenous (IV) Equipments Market Size of Pregnancy (2017 to 2028) in USD Million
Table 19: Japan Intravenous (IV) Equipments Market Size of Diabetes (2017 to 2028) in USD Million
Table 20: Japan Intravenous (IV) Equipments Market Size of Respiratory Diseases (2017 to 2028) in USD Million
Table 21: Japan Intravenous (IV) Equipments Market Size of Cancer (2017 to 2028) in USD Million
Table 22: Japan Intravenous (IV) Equipments Market Size of Movement Disorders (2017 to 2028) in USD Million
Table 23: Japan Intravenous (IV) Equipments Market Size of Cancer (2017 to 2028) in USD Million
Table 24: Japan Intravenous (IV) Equipments Market Size of Movement Disorders (2017 to 2028) in USD Million
List of Figures
Figure 1: Japan Intravenous (IV) Equipments Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 2: Market Attractiveness Index, By Product
Figure 3: Market Attractiveness Index, By End-Use
Figure 4: Market Attractiveness Index, By Indication
Figure 5: Porter's Five Forces of Japan Intravenous (IV) Equipments Market
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More